Trial Profile
The Phase I/II randomized controlled clinical study to evaluate pharmacodynamics of micro-formulation over conventional eyedroppers.
Status:
Completed
Phase of Trial:
Phase I/II
Latest Information Update: 06 Dec 2016
Price :
$35
*
At a glance
- Drugs Phenylephrine/tropicamide (Primary)
- Indications Mydriasis
- Focus Pharmacodynamics
- 06 Dec 2016 New trial record
- 28 Nov 2016 According to Eyenovia media release, results were published in the peer-review journal Therapeutic Delivery.